Navigation Links
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
Date:11/9/2011

PARIS and TARRYTOWN, N.Y., Nov. 10, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive preliminary results from the Phase 2 study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C) were treated with REGN727/SAR236553.

REGN727/SAR236553 is a novel, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9).  Blocking the PCSK9 pathway is a novel mechanism for lowering LDL-C, the leading known risk factor for coronary artery disease.

One Phase 2 trial studied patients with heterozygous familial hypercholesterolemia (heFH) with elevated cholesterol (LDL-C>/=100mg/dL) despite lipid lowering therapy (statins with or without ezetemibe).  The objective of the study was to compare the effect of adding REGN727/ SAR236553 to the existing lipid lowering therapy in heFH patients.  In the primary efficacy analysis of the study, after 12 weeks of treatment, patients who received different dosing regimens of REGN727/SAR236553 achieved mean LDL-C reductions from baseline ranging from approximately 30% to greater than 65% depending on the dosing regimen of REGN727/SAR236553 compared to a mean reduction of 10% with placebo (p<0.05 for all dose groups).  Patients in the study are being followed for a total of 20 weeks for safety.

In this trial, REGN727/SAR236553 was generally well tolerated over 12 weeks.  There were no elevations in LFTs >3 times the upper limit of normal (ULN) and no cases of elevated CPK reported.  The most common adverse event was injection site reaction.  There were no serious adverse events on active treatment.  Full safety data from the 8-week po
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... PARK, Calif. , July 28, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based ... announced the publication of the SENZA-RCT results in ... official Journal of the American Society of Anesthesiologists. ... a ground-breaking study that was the first to ...
(Date:7/28/2015)... CHICAGO , July 28, 2015 The ... a patient safety fundraising campaign, " Surviving Your Hospital ... receiving the care they deserve! None of these patients ... JD (Founder and Executive Director, PPAHS) referring to the ... of the National Coalition to Promote Continuous Monitoring ...
(Date:7/28/2015)... DUBLIN , July 28, 2015 ... the addition of the "Global Hearing Aids ... The global hearing aids market to ... period 2014-2019. Factors such as ... are driving market growth. The market has witnessed ...
Breaking Medicine Technology:Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... announces the Lost and Found, a breakthrough technological invention. It is a ... for the consumer electronic industry reached a record high of $211.3 billion in ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... co-host “The Soul of Philanthropy Reframed and Exhibited,” a photographic and narrative exploration ... Street, in Denver’s historic Five Points neighborhood. , Denver is one of only ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was the ... nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The system ... , The CoreValve® Evolut® R System was approved by the U.S. Food and Drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... Autism ... in 68 children currently affected with the disorder. For these families, identifying and ... to recovery is extremely daunting. That’s where Talk About Curing Autism (TACA), a ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... U.S. President Barack Obama’s visit to Ethiopia to learn more about the impact ... Future Initiative . This initiative focuses on accelerating agricultural development as an engine ...
Breaking Medicine News(10 mins):Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
... spot inflammation-related enzyme that may be major contributor to ... An enzyme linked to inflammation boosts the risk of ... high cholesterol, a new study suggests. , Researchers think ... lipoprotein-associated phospholipase A2, they may have another weapon to ...
... ... Illness (NAMI), NAMIWalks help raise funds for local programs. , ... (PRWEB) -- May is Mental Health Month. This weekend, Saturday ... NAMIWalks to raise public awareness about facts concerning mental illness and the ...
... Shah ... Talecris to the legislative and executive branches of government in Washington, D.C. ... Research Triangle Park, NC (Vocus) ... Nimish Shah has joined the public affairs department as vice president, federal government relations., , ...
... ... Cortical Concepts Wins ,Wharton Business Plan Competition Michelson Grand Prize with ,Device that ... Private Sales for Co-eds, , ... Philadelphia, PA (PRWEB) April 29, 2010 -- The Wharton ...
... (April 29, 2010) Unchecked, the natural or innate immune ... accelerator on a car. Eventually, it will kill the host ... directed at understanding how this innate immune system is turned ... regulated. That is important because the innate immune system is ...
... ... alcohol regulations to keep them safe, according to a new poll conducted by a bipartisan ... showed that 75% of adults support “the rights of individual states to set their own ... ...
Cached Medicine News:Health News:Watch Your Cholesterol, Your Blood Pressure ... and This Enzyme? 2Health News:NAMIWalks Kicks-off &#8220;Mental Health Month&#8221;; Fun Events that Support Serious Work 2Health News:Talecris Biotherapeutics Hires Nimish Shah as Vice President, Federal Government Relations 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 2Health News:Wharton Business Plan Competition Michelson Grand Prize Winners Announced 3Health News:A single protein regulates 2 immune pathways 2Health News:Survey Finds Broad Support for Alcohol Regulations to Keep the Public Safe 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medium....
Large deep curve....
Medicine Products: